Cargando…

Managing patients with rheumatic diseases treated with rituximab during the COVID-19 pandemic

Detalles Bibliográficos
Autor principal:	Dougados, Maxime
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993927/ https://www.ncbi.nlm.nih.gov/pubmed/33786453 http://dx.doi.org/10.1016/S2665-9913(21)00077-1

Ejemplares similares

Navigating use of rituximab during the COVID-19 pandemic
por: Elahee, Mehreen, et al.
Publicado: (2023)

Effect of the COVID-19 pandemic on patients with systemic rheumatic diseases
por: Antonelli, Alessandro, et al.
Publicado: (2021)

Rituximab during the COVID-19 pandemic: time to discuss treatment options with patients
por: Boekel, L, et al.
Publicado: (2022)

Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseases
por: Felten, Renaud, et al.
Publicado: (2021)

COVID-19 in patients with rheumatic disease: finally, a denominator
por: Wallace, Daniel J
Publicado: (2021)

Post-COVID-19 condition in patients with autoimmune rheumatic diseases: the COVID-19 Vaccination in Autoimmune Diseases (COVAD) study
por: Sen, Parikshit, et al.
Publicado: (2023)

Management of patients with multiple myeloma during the COVID-19 pandemic
por: Malard, Florent, et al.
Publicado: (2020)

Changing COVID-19 outcomes in patients with rheumatic disease—are we really getting better at this?
por: Gianfrancesco, Milena A, et al.
Publicado: (2021)

First data on COVID-19 morbidity and mortality in patients with rheumatic disease from South Korea
por: Schreiber, Karen, et al.
Publicado: (2021)

COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases
por: Boekel, Laura, et al.
Publicado: (2022)

Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination
por: Barbhaiya, Medha, et al.
Publicado: (2022)

What does endemic COVID-19 mean for the future of rituximab?
por: Liew, David F L, et al.
Publicado: (2022)

Managing fragility fractures during the COVID-19 pandemic
por: Napoli, Nicola, et al.
Publicado: (2020)

Patients with rheumatic diseases adhere to COVID-19 isolation measures more strictly than the general population
por: Hooijberg, Femke, et al.
Publicado: (2020)

Depression and anxiety disorders during the COVID-19 pandemic: knowns and unknowns
por: Taquet, Maxime, et al.
Publicado: (2021)

Real-world evidence for prehospital COVID-19 treatment in systemic autoimmune rheumatic disease
por: Bechman, Katie, et al.
Publicado: (2023)

Importance of nociplastic pain in patients with rheumatic diseases
por: Alcántara Montero, Antonio
Publicado: (2023)

Long COVID in inflammatory rheumatic diseases—what's in a name?
por: Calabrese, Leonard H
Publicado: (2023)

COVID-19 in patients with cancer: managing a pandemic within a pandemic
por: Horn, Leora, et al.
Publicado: (2020)

Cellular and humoral immunity after the third dose of SARS-CoV-2 vaccine in patients treated with rituximab
por: Felten, Renaud, et al.
Publicado: (2022)

Acceptability of the COVID-19 vaccine among patients with chronic rheumatic diseases and health-care professionals: a cross-sectional study in 19 Arab countries
por: El Kibbi, Lina, et al.
Publicado: (2022)

A small contribution to mitigate the collision of transmissible and chronic diseases, exemplified by the management of hypertension during the COVID-19 pandemic
por: Valdés, Gloria, et al.
Publicado: (2020)

Kawasaki-like disease: emerging complication during the COVID-19 pandemic
por: Viner, Russell M, et al.
Publicado: (2020)

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
por: Avouac, Jérôme, et al.
Publicado: (2021)

Ongoing asthma management in children during the COVID-19 pandemic: to step down or not to step down?
por: Abrams, Elissa Michele, et al.
Publicado: (2021)

Asthma in children during the COVID-19 pandemic: lessons from lockdown and future directions for management
por: Gupta, Atul, et al.
Publicado: (2020)

ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group
por: Cortese, Samuele, et al.
Publicado: (2020)

Improving family access to dying patients during the COVID-19 pandemic
por: Downar, James, et al.
Publicado: (2021)

Strategies for managing patients with psychiatric illness in the reopening period of the COVID-19 pandemic in China
por: Bai, Wei, et al.
Publicado: (2022)

Childhood cancer control during the COVID-19 pandemic
por: Luna-Fineman, Sandra, et al.
Publicado: (2021)

Influenza lineage extinction during the COVID-19 pandemic?
por: Koutsakos, Marios, et al.
Publicado: (2021)

Diabetic ketoacidosis risk during the COVID-19 pandemic
por: Vellanki, Priyathama, et al.
Publicado: (2021)

Electroconvulsive therapy practice during the COVID-19 pandemic
por: Bellini, Helena, et al.
Publicado: (2020)

Maintaining HIV care during the COVID-19 pandemic
por: Jiang, Hongbo, et al.
Publicado: (2020)

Suicide risk and prevention during the COVID-19 pandemic
por: Gunnell, David, et al.
Publicado: (2020)

Combating physical inactivity during the COVID-19 pandemic
por: Pinto, Ana Jéssica, et al.
Publicado: (2020)

Provision of cancer care during the COVID-19 pandemic
por: Spicer, James, et al.
Publicado: (2020)

Mitigating the risks of surgery during the COVID-19 pandemic
por: Myles, Paul S, et al.
Publicado: (2020)

Attitudes to cataract surgery during the COVID-19 pandemic: a patient survey
por: Naderi, Khayam, et al.
Publicado: (2020)

Prevention and control strategies for the diagnosis and treatment of cancer patients during the COVID-19 pandemic
por: Tan, Juan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7lpnmfm7cg4kfnib1q7oq426sd